GeneDx Holdings Earnings Estimates, EPS & Revenue | NASDAQ:WGS

Comments

GeneDx Holdings Corp Earnings Estimates

WGSNASDAQ

Trade with Public

$88.11

6.117.45%

At close: Mar 6, 4:00 PM EST

$88.11

N/A

After Hours: 4:00 PM EST

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Stock Report

GeneDx Holdings Earnings Estimates, EPS & Revenue | NASDAQ:WGS

GeneDx Holdings (WGS) is scheduled to report Q1 earnings on April 29, 2026. Analysts estimate EPS of $-0.04 and quarterly revenue of $116.25M.

In the most recent quarter (Q4), GeneDx Holdings reported EPS of $0.14, beating estimates of $0.12 by 0.17%. Revenue came in at $120.99M, exceeding the estimate of $119.94M by 0.01%.

GeneDx Holdings has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, GeneDx Holdings has averaged an EPS surprise of 1.62% and a revenue surprise of 0.11%.

Earnings Date

Apr 29

EPS Estimate

$-0.040

Quarterly Revenue Estimate

$116.25M

Annual Revenue
(as of Sep 30)

$402.19M

GeneDx Holdings Earnings History

Analyze the earnings history of GeneDx Holdings using advanced sorting and filters.

GeneDx Holdings (WGS) Earnings Per Share

The chart below shows GeneDx Holdings's reported EPS compared to analyst estimates over recent quarters.

GeneDx Holdings (WGS) Revenue

The chart below shows GeneDx Holdings's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is GeneDx Holdings (NASDAQ:WGS) reporting earnings?

GeneDx Holdings (WGS) is scheduled to report earnings on April 29, 2026. The last reported earnings were for reported on February 23, 2026 for Q4.

What were the latest earnings per share (EPS) for GeneDx Holdings (NASDAQ:WGS)?

The Actual EPS was $0.14, which beat the estimate of $0.12.

What were GeneDx Holdings’s (NASDAQ:WGS) revenues?

The Actual Revenue was $120.99M, which beat the estimate of $119.94M.

People Also Watch

Aveanna Healthcare Holdings Inc

Hims & Hers Health Inc

NYSE:HIMS

$15.71

-0.19%

Privia Health Group Inc

NASDAQ:PRVA

$23.27

InnovAge Holding Corp

GeneDx Holdings Earnings Estimates, EPS & Revenue | NASDAQ:WGS

GeneDx Holdings (WGS) is scheduled to report Q1 earnings on April 29, 2026. Analysts estimate EPS of $-0.04 and quarterly revenue of $116.25M.

In the most recent quarter (Q4), GeneDx Holdings reported EPS of $0.14, beating estimates of $0.12 by 0.17%. Revenue came in at $120.99M, exceeding the estimate of $119.94M by 0.01%.

GeneDx Holdings has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, GeneDx Holdings has averaged an EPS surprise of 1.62% and a revenue surprise of 0.11%.

Earnings Date

Apr 29

EPS Estimate

$-0.040

Quarterly Revenue Estimate

$116.25M

Annual Revenue
(as of Sep 30)

$402.19M